CRBP

CORBUS PHARMACEUTICALS HLDGS

CRBP·21833P301·US·Common Stock·Healthcare - Biotechnology-13D/G

CRBP (CORBUS PHARMACEUTICALS HLDGS) is held by 59 institutional investors as of Q1 2026. Largest holders: Aberdeen Group plc ($12.4M), VANGUARD CAPITAL MANAGEMENT LLC ($6.9M), CITADEL ADVISORS LLC ($6.8M). Net institutional sentiment: Mixed.

59
Holders
Avg rating(13 Elite)
$52.8M
Total Value
61% (65)
Fund Consensus
34 buying - 22 selling
CRBPSmart Money Verdict
View all
Held by 59 funds
13 elite
Who's Trading
ActivistOAOctagon Capital Advisors LP0.0%May 14, 2026
InsiderSDSmethurst DominicSell $51KMar 2, 2026
InsiderHIHodgson IanSell $6KFeb 17, 2026
InsiderCYCohen YuvalSell $108KFeb 13, 2026
InsiderMFMoran Sean F.Sell $37KFeb 13, 2026
ActivistAberdeen Group plcAberdeen Group plc7.5%Jan 16, 2026
ActivistCACormorant Asset Management, LP13.4%Dec 15, 2025
InsiderCLCormorant Asset Management, LPSell $344KDec 11, 2025
ActivistCitadel Advisors LLCCitadel Advisors LLC4.7%Nov 12, 2025
InsiderCYCohen YuvalSell $154KOct 27, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1.3M$12.4M0.0%+11.31%
0
New
734,106$6.9M0.0%+17.90%
38
Decreased
727,060(-13.8%)$6.8M0.0%+20.85%
0
Decreased
346,998(-2.1%)$3.3M0.0%+18.33%
0
Increased
333,415(+46.4%)$3.1M0.0%+3.92%
36
Increased
271,636(+1.3%)$2.6M0.0%-15.18%
18
Increased
187,029(+9.4%)$1.8M0.0%-72.55%
28
Decreased
160,462(-11.9%)$1.5M0.0%-39.87%
0
Increased
146,596(+89.0%)$1.4M0.0%-1.77%
40
Increased
136,602(+76.6%)$1.3M0.0%+19.55%
38
Increased
107,800(+190.8%)$1M0.0%-8.19%
40
New
96,241$903,7030.0%+17.90%
34
Increased
93,111(+96.3%)$874,3130.0%+1.52%
40
Decreased
85,246(-54.6%)$800,4600.0%-2.61%
0
Increased
73,193(+160.8%)$687,2820.0%-10.46%
40
Increased
68,872(+25.0%)$646,7080.0%-69.71%
20
Decreased
65,201(-51.1%)$612,2370.0%+10.55%
0
New
52,836$496,1300.0%+17.90%
33
Decreased
51,296(-31.7%)$481,6690.0%+20.85%
0
Decreased
41,504(-0.5%)$389,7230.0%-49.08%
0

Showing 1-20 of 65

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used